Printer Friendly

JONES MEDICAL REPORTS YEAR END RESULTS WITH RECORD SALES OF $24 MILLION

 ST. LOUIS, Feb. 16 /PRNewswire/ -- Jones Medical Industries, Inc. (NASDAQ: JMED) today reported record sales and earnings for the eleventh consecutive year ended Dec. 31, 1992.
 Sales for 1992 were $24,057,000 with net income of $3,732,000 or $.40 per share compared to 1991 results of $20,513,000, $3,294,000 and $.36 respectively. Sales increased $3,544,000 or 17.3 percent, pretax income $887,000 or 17.2 percent, net income $438,000 or 13.3 percent and earnings per share $.04 or 11.1 percent. Average shares outstanding during 1992 were 9,446,000 compared to 9,251,000 during 1991.
 Sales for the fourth quarter ended Dec. 31, 1992 were up $786,000 or 13.1 percent to $6,794,000, pretax income was up $198,000 or 11.6 percent, however, net income was down $44,000 to $1,160,000 or 3.7 percent and earnings per share was $.12 with 9,444,000 average shares outstanding compared to $.13 with 9,439,000 average shares outstanding for the 1991 fourth quarter.
 Mr. Dennis Jones, chairman and CEO said, "The highlight of this, our eleventh year of operations, was the increase in sales from internally generated growth of the Company's Branded Products. Only 18 percent of the 1992 sales increase was from the timing of our May 1991 acquisition of GenTrac Incorporated. The vast majority of the increase was from growing Thrombinar, Therevac, Liqui-Char and the Company's Branded Vitamin products."
 "Fourth quarter 1992 sales would normally have been even stronger" Mr. Jones continued, "except for the fact that wholesalers, for the most part, did not place large year end orders, as has been our industries experience in the past. The reason for this aberration is still not clear to us. In any event, we ended the year as usual on a strong note. Now with the previously announced acquisition of $2.4 million in historical sales of the Derma System Professional Skin Care products together with lower wholesale stock levels, we believe that the opportunity to achieve a 25 percent increase in sales to $30 million with a 30 percent increase in profits to around $5 million is possible for 1993."
 Following is the comparative results for the 1992 year end and fourth quarter:
 JONES MEDICAL INDUSTRIES, INC.
 YEAR ENDED DECEMBER 31: 1992 1991
 Revenues $24,057,000 $20,513,000
 Net Income 3,732,000 3,294,000
 Average Shares Outstanding 9,446,000 9,251,000
 Per share earnings $ .40 $ .36
 QUARTER ENDED DECEMBER 31: 1992 1991
 Revenues $ 6,794,000 $ 6,008,000
 Net Income 1,160,000 1,204,000
 Average Shares Outstanding 9,444,000 9,439,000
 Per share earnings $ .12 $ .13
 -0- 2/16/93
 /CONTACT: Andrea Holmes of Jones Medical Industries, Inc., 314-432-7557/
 (JMED)


CO: Jones Medical Industries, Inc. ST: Missouri IN: HEA SU: ERN

LR -- NY040 -- 6787 02/16/93 10:04 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 16, 1993
Words:492
Previous Article:JONES MEDICAL INDUSTRIES ANNOUNCES ACQUISITION
Next Article:SUN DISTRIBUTORS L.P. ANNOUNCES CASH DISTRIBUTIONS
Topics:


Related Articles
JONES MEDICAL REPORTS TENTH CONSECUTIVE RECORD YEAR
JONES MEDICAL REPORTS RECORD SECOND QUARTER EARNINGS PER SHARE OF 9 CENTS UP 29 PERCENT
COMDISCO ANNOUNCES FOURTH QUARTER AND 1992 YEAR END RESULTS; DECLARES QUARTERLY CASH DIVIDEND
WHITMAN REPORTS RESULTS
JONES MEDICAL REPORTS UNUSUALLY LARGE APRIL 1993 THROMBINAR SALES
JONES MEDICAL REPORTS RECORD FIRST QUARTER WITH NET INCOME UP 16 PERCENT
HOMEDCO GROUP INC. REPORTS SECOND QUARTER EARNINGS; ANNOUNCES NEW CREDIT LINE FOR ACQUISITIONS; AND THE ADOPTION OF A SHAREHOLDER RIGHTS PLAN
JONES MEDICAL REPORTS RECORD QUARTERLY EARNINGS RECEIVES FIRST FDA RELEASE OF HIGH-PURITY THROMBIN
MENTOR REPORTS RECORD FIRST QUARTER RESULTS
MENTOR REPORTS RECORD FIRST QUARTER RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters